Found: 13
Select item for more details and to access through your institution.
Neuroprotection of retinal ganglion cells by the sigma-1 receptor agonist pridopidine in models of experimental glaucoma.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-01077-w
- By:
- Publication type:
- Article
Sigma-1 Receptor (S1R) Interaction with Cholesterol: Mechanisms of S1R Activation and Its Role in Neurodegenerative Diseases.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 8, p. 4082, doi. 10.3390/ijms22084082
- By:
- Publication type:
- Article
Poor Cerebral Inflammatory Response in eIF2B Knock-In Mice: Implications for the Aetiology of Vanishing White Matter Disease.
- Published in:
- PLoS ONE, 2012, v. 7, n. 10, p. 1, doi. 10.1371/journal.pone.0046715
- By:
- Publication type:
- Article
Pridopidine reduces mutant huntingtin-induced endoplasmic reticulum stress by modulation of the Sigma-1 receptor.
- Published in:
- Journal of Neurochemistry, 2021, v. 158, n. 2, p. 467, doi. 10.1111/jnc.15366
- By:
- Publication type:
- Article
Pridopidine reduces mutant huntingtin‐induced endoplasmic reticulum stress by modulation of the Sigma‐1 receptor.
- Published in:
- Journal of Neurochemistry, 2021, v. 158, n. 1, p. 467, doi. 10.1111/jnc.15366
- By:
- Publication type:
- Article
A mouse model for eukaryotic translation initiation factor 2B-leucodystrophy reveals abnormal development of brain white matter.
- Published in:
- Brain: A Journal of Neurology, 2010, v. 133, n. 8, p. 2448, doi. 10.1093/brain/awq180
- By:
- Publication type:
- Article
Pridopidine activates neuroprotective pathways impaired in Huntington Disease.
- Published in:
- Human Molecular Genetics, 2016, v. 25, n. 18, p. 3975, doi. 10.1093/hmg/ddw238
- By:
- Publication type:
- Article
Targeting the Sigma-1 Receptor via Pridopidine Ameliorates Central Features of ALS Pathology in a SOD1<sup>G93A</sup> Model.
- Published in:
- Cell Death & Disease, 2019, v. 10, n. 3, p. 1, doi. 10.1038/s41419-019-1451-2
- By:
- Publication type:
- Article
Pridopidine, a clinic-ready compound, reduces 3,4-dihydroxyphenylalanine-induced dyskinesia in Parkinsonian macaques.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Large-scale transcriptomic analysis reveals that pridopidine reverses aberrant gene expression and activates neuroprotective pathways in the YAC128 HD mouse.
- Published in:
- Molecular Neurodegeneration, 2018, v. 13, n. 1, p. N.PAG, doi. 10.1186/s13024-018-0259-3
- By:
- Publication type:
- Article
Pridopidine Does Not Significantly Prolong the QTc Interval at the Clinically Relevant Therapeutic Dose.
- Published in:
- Neurology & Therapy, 2023, v. 12, n. 2, p. 597, doi. 10.1007/s40120-023-00449-w
- By:
- Publication type:
- Article
Impairment and Restoration of Homeostatic Plasticity in Cultured Cortical Neurons From a Mouse Model of Huntington Disease.
- Published in:
- Frontiers in Cellular Neuroscience, 2019, p. N.PAG, doi. 10.3389/fncel.2019.00209
- By:
- Publication type:
- Article
Sigma-1 and dopamine D2/D3 receptor occupancy of pridopidine in healthy volunteers and patients with Huntington disease: a [18F] fluspidine and [18F] fallypride PET study.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 4, p. 1103, doi. 10.1007/s00259-020-05030-3
- By:
- Publication type:
- Article